Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TREATMENT OF HEMATOLOGIC CANCER WITH PD-1/CD3 DUAL SPECIFICITY PROTEIN
Document Type and Number:
WIPO Patent Application WO/2021/006199
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing a novel drug for preventing hematologic cancer, suppressing the progression of a symptom of hematologic cancer, suppressing the recurrence of hematologic cancer or treating hematologic cancer. The present inventors have studied extensively and intensively. As a result, the present inventors have focused attention on a dual specificity protein having a first arm capable of binding specifically to PD-1 and a second arm capable of binding specifically to CD3 (preferably a PD-1/CD3 dual specificity antibody or an antibody fragment thereof) as a substance that can solve the problem, and have found that the dual specificity protein is useful for the prevention of hematologic cancer, the suppression of the progression of a symptom of hematologic cancer, the suppression of the recurrence of hematologic cancer or the treatment of hematologic cancer.

Inventors:
SHIBAYAMA SHIRO (JP)
SHIMBO TAKUYA (JP)
Application Number:
PCT/JP2020/026149
Publication Date:
January 14, 2021
Filing Date:
July 03, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ONO PHARMACEUTICAL CO (JP)
International Classes:
A61K39/395; A61K45/00; A61P35/00; A61P35/02; C07K16/28; C07K16/30; C07K16/46; C12N15/13; C12N15/62
Domestic Patent References:
WO2003011911A12003-02-13
WO2004072286A12004-08-26
WO2019070047A12019-04-11
WO2019156199A12019-08-15
WO2003011911A12003-02-13
WO2004072286A12004-08-26
WO2013022091A12013-02-14
WO2005118635A22005-12-15
WO2001064942A12001-09-07
WO1995019374A11995-07-20
WO2000063243A12000-10-26
WO1999016873A11999-04-08
WO2001004144A22001-01-18
WO2004106368A12004-12-09
WO2011023685A12011-03-03
WO2002043478A22002-06-06
WO2004009618A22004-01-29
WO2009157771A22009-12-30
WO2014051433A12014-04-03
WO2004056875A12004-07-08
WO2006121168A12006-11-16
WO2008156712A12008-12-24
WO2010029434A12010-03-18
WO2010029435A12010-03-18
WO2010036959A22010-04-01
WO2011110604A12011-09-15
WO2011110621A12011-09-15
WO2014179664A22014-11-06
WO2014194302A22014-12-04
WO2014206107A12014-12-31
WO2015035606A12015-03-19
WO2015036394A12015-03-19
WO2015085847A12015-06-18
WO2015112800A12015-07-30
WO2016014688A22016-01-28
WO2016015685A12016-02-04
WO2016068801A12016-05-06
WO2016077397A22016-05-19
WO2016092419A12016-06-16
WO2016106159A12016-06-30
WO2016127179A22016-08-11
WO2016197497A12016-12-15
WO2016210129A12016-12-29
WO2017011580A22017-01-19
WO2017016497A12017-02-02
WO2017019846A12017-02-02
WO2017024465A12017-02-16
WO2017024515A12017-02-16
WO2017025016A12017-02-16
WO2017025051A12017-02-16
WO2017040790A12017-03-09
WO2017055443A12017-04-06
WO2017055547A12017-04-06
WO2017058115A12017-04-06
WO2017058859A12017-04-06
WO2017079112A12017-05-11
WO2017079116A22017-05-11
WO2017087599A12017-05-26
WO2017096026A12017-06-08
WO2017106656A12017-06-22
WO2017107885A12017-06-29
WO2017124050A12017-07-20
WO2017125815A22017-07-27
WO2017132827A12017-08-10
WO2017133540A12017-08-10
WO2017166804A12017-10-05
WO2017198741A12017-11-23
WO2017201766A12017-11-30
WO2017214182A12017-12-14
WO2018020476A12018-02-01
WO2018026248A12018-02-08
WO2018034226A12018-02-22
WO2018036472A12018-03-01
WO2018052818A12018-03-22
WO2018053106A12018-03-22
WO2018068336A12018-04-19
WO2018085358A12018-05-11
WO2018085468A12018-05-11
WO2018087143A22018-05-17
WO2018091661A12018-05-24
WO2018113258A12018-06-28
WO2018119474A22018-06-28
WO2018162944A12018-09-13
WO2018192089A12018-10-25
WO2018210230A12018-11-22
WO2018217227A12018-11-29
WO2018226580A22018-12-13
WO2019005635A22019-01-03
WO2019051164A12019-03-14
WO2018223004A12018-12-06
WO2018223002A12018-12-06
WO2018114754A12018-06-28
WO2017070943A12017-05-04
WO2017053856A12017-03-30
WO2017021349A12017-02-09
WO2017021354A12017-02-09
WO2016179003A12016-11-10
WO2016014974A22016-01-28
WO2016016859A12016-02-04
WO2014151438A12014-09-25
WO2013186613A12013-12-19
WO2010052013A12010-05-14
WO2010037836A22010-04-08
WO2007042261A22007-04-19
WO2007033230A22007-03-22
WO2003026692A22003-04-03
WO2000005268A12000-02-03
WO2010037835A22010-04-08
WO2013157953A12013-10-24
WO2013157954A12013-10-24
WO2000063403A22000-10-26
Foreign References:
JP2011525808A2011-09-29
US4474893A1984-10-02
US4816567A1989-03-28
US5223409A1993-06-29
US5403484A1995-04-04
US5571698A1996-11-05
US5427908A1995-06-27
US5580717A1996-12-03
US5969108A1999-10-19
US6172197B12001-01-09
US5885793A1999-03-23
US6521404B12003-02-18
US6544731B12003-04-08
US6555313B12003-04-29
US6582915B12003-06-24
US6593081B12003-07-15
US5225539A1993-07-06
US5530101A1996-06-25
US5585089A1996-12-17
US6180370B12001-01-30
US5545806A1996-08-13
US5569825A1996-10-29
US5625126A1997-04-29
US5633425A1997-05-27
US5789650A1998-08-04
US5877397A1999-03-02
US5661016A1997-08-26
US5814318A1998-09-29
US5874299A1999-02-23
US5770429A1998-06-23
US5939598A1999-08-17
US6075181A2000-06-13
US6114598A2000-09-05
US6150584A2000-11-21
US6162963A2000-12-19
US5476996A1995-12-19
US5698767A1997-12-16
US20180312564A12018-11-01
US20190016823A12019-01-17
US20180291114A12018-10-11
CN107501412A2017-12-22
CN106810611A2017-06-09
US20170218079A12017-08-03
US20170174779A12017-06-22
CN106349391A2017-01-25
CN106084049A2016-11-09
US20160176980A12016-06-23
US20150266966A12015-09-24
CN104098698A2014-10-15
CN102219856A2011-10-19
CN106084046A2016-11-09
CN106146661A2016-11-23
EP0120694A21984-10-03
EP0314161A11989-05-03
EP0481790A21992-04-22
EP0523949A11993-01-20
US4801687A1989-01-31
US5151504A1992-09-29
Other References:
INABA, TOORU: "Angioimmunoblastic T- cell lymphoma: AITL", JOURNAL OF CLINICAL LABORATORY MEDICINE, vol. 57, 30 November 2012 (2012-11-30), JP , pages 1634 - 1637, XP009533204, ISSN: 0485-1420
HUANG, JINGYING, TAN JIAXIONG, CHEN YOUCHUN, HUANG SHUXIN, XU LING, ZHANG YIKAI, LU YUHONG, YU ZHI, CHEN SHAOHUA, LI YANGQIU: "A skewed distribution and increased PD-1+Vbeta+ CD 4+/ CD 8+ T cells in patients with acute myeloid leukemia.", J. LEUKOC. BIOL., vol. 106, no. 3, 28 May 2019 (2019-05-28), pages 725 - 732, XP055783477, DOI: 10.1002/JLB.MA0119-021R
"GenBank", Database accession no. NP 005009
CURRENT OPINION IN BIOTECHNOLOGY, vol. 17, no. 6, 2006, pages 653 - 658
CURRENT OPINION IN BIOTECHNOLOGY, vol. 18, 2007, pages 1 - 10
CURRENT OPINION IN STRUCTURAL BIOLOGY, vol. 7, 1997, pages 463 - 469
PROTEIN SCIENCE, vol. 15, 2006, pages 14 - 27
J. SYNTH. ORG. CHEM., JPN., vol. 75, no. 11, 2017, pages 1171 - 1178
NATURE BIOTECHNOLOGY, vol. 23, 2005, pages 1556 - 1561
NATURE BIOTECHNOLOGY, vol. 22, 2004, pages 575 - 582
NATURE, vol. 430, no. 6996, 2004, pages 174 - 180
JOURNAL OF MOLECULAR BIOLOGY, vol. 383, no. 5, 2008, pages 1058 - 1068
PROC. NATL. ACAD. SCI. USA, vol. 90, no. 14, 1993, pages 6444 - 6448
J. BIOLOGICAL CHEMISTRY, vol. 269, 1994, pages 199 - 206
BIOCHEMISTRY, vol. 31, no. 6, 1992, pages 1579 - 1584
KOHLERMILSTEIN ET AL., NATURE, vol. 256, 1975, pages 495 - 97
HONGO ET AL., HYBRIDOMA, vol. 14, no. 3, 1995, pages 253 - 260
HARLOW ET AL.: "Antibodies: A Laboratory Manual", vol. 2, 1988, COLD SPRING HARBOR LABORATORY PRESS
HAMMERLING ET AL.: "Monoclonal Antibodies and T-Cell Hybridomas", 1981, ELSEVIER, pages: 563 - 681
TOMIZUKA ET AL., PROC. NATL. ACAD. SCI. USA, 2000, pages 722 - 727
DE WILDT RM ET AL., J. MOL. BIOL., vol. 285, 1999, pages 895 - 901
KRUIF ET AL., J. MOL. BIOL., vol. 387, 2009, pages 548 - 58
"Sequences of Proteins of Immunological Interest", 1987, NATIONAL INSTITUTE OF HEALTH
COLIGAN JE, DUNN BM, PLOEGH HL, SPEICHER DW, WINGFIELD PT: "Current Protocols in Protein Science", 1995
"Mammalian Cell Biotechnology: a Practical Approach", 1991, IRL PRESS
GENESIS, vol. 47, no. 6, June 2009 (2009-06-01), pages 414 - 22
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: